期刊文献+

肉灵芝提取物调控长链非编码RNA BRCA1相邻基因2/双特异性磷酸酶4/细胞外信号调节激酶通路对肝癌细胞Hep3B增殖及凋亡的影响

Effects of Ganoderma lucidum extract on the proliferation and apoptosis of Hep3B hepatocellular carcinoma cells by regulating the lncRNA NBR2/DUSP4/ERK pathway
下载PDF
导出
摘要 目的探讨肉灵芝提取物是否可通过长链非编码RNA BRCA1相邻基因2(LncRNA NBR2)/双特异性磷酸酶4/细胞外信号调节激酶(DUSP4/ERK)通路而影响肝癌HepB细胞增殖及凋亡。方法体外培养肝癌HepB细胞,分为1 mg/L肉灵芝提取物组、2 mg/L肉灵芝提取物组、4 mg/L肉灵芝提取物组、si-NC组、si-LncRNA NBR2组、pcDNA-NC组、pcDNA-LncRNA NBR2组、肉灵芝提取物+si-NC组、肉灵芝提取物+si-LncRNA NBR2组;采用MTT检测肝癌HepB细胞增殖;流式细胞术检测肝癌HepB细胞凋亡;RT-qPCR检测LncRNA NBR2的表达量;蛋白质印迹法(Western blotting)检测增殖细胞核抗原(PCNA)、活化的含半胱氨酸的天冬氨酸蛋白水解酶3(Cleaved-caspase-3)、DUSP4、p-ERK蛋白表达量。结果肉灵芝提取物可明显降低肝癌HepB细胞增殖率与PCNA、DUSP4、p-ERK蛋白水平(P<0.05),提高肝癌HepB细胞凋亡率、Cleaved-caspase-3蛋白水平及LncRNA NBR2的表达水平(P<0.05);转染si-LncRNA NBR2后可明显提高肝癌HepB细胞增殖率及PCNA、DUSP4、p-ERK蛋白水平(P<0.05),降低凋亡率及Cleaved-caspase-3蛋白水平(P<0.05),而转染pcDNA-NBR2可明显减弱转染si-LncRNA NBR2对肝癌HepB细胞增殖及凋亡的作用;与肉灵芝提取物+si-NC组比较,肉灵芝提取物+si-LncRNA NBR2组肝癌HepB细胞增殖率及PCNA、DUSP4、p-ERK蛋白水平升高(P<0.05),凋亡率及Cleaved-caspase-3蛋白水平降低(P<0.05)。结论肉灵芝提取物可通过上调LncRNA NBR2的表达而抑制DUSP4/ERK信号通路的活化从而抑制肝癌HepB细胞增殖及诱导细胞凋亡。 Objective To investigate whether Ganoderma lucidum extract can affect the proliferation and apoptosis of Hep3B liver cancer cells through the long noncoding RNA BRCA1 adjacent gene 2(lnc RNA NBR2)/dual specificity phosphatase 4/extracellular signal-regulated kinase(DUSP4/ERK)pathway.Methods Hep3B cells were cultured in vitro and divided into the 1 mg/L Ganoderma lucidum extract group,2 mg/L Ganoderma lucidum extract group,4 mg/L Ganoderma lucidum extract group,si-NC group,si-lnc RNA NBR2 group,pc DNA-NC group,pc DNA-lnc RNA NBR2 group,Ganoderma extract+si-NC group,and Ganoderma extract+si-lnc RNA NBR2 group.MTT was used to detect the proliferation of Hep3B cells,and flow cytometry was used to detect the apoptosis of Hep3B cells.RT-qPCR was used to detect the expression of lnc RNA NBR2;Western blot was used to detect proliferating cell nuclear antigen(PCNA),activated cysteine-containing caspase-3(Cleaved-caspase-3),DUSP4,and p-ERK protein expression.Results Ganoderma lucidum extract can significantly reduce the proliferation rate of Hep3B cells and the protein levels of PCNA,DUSP4,and p-ERK(P<0.05)and increased the apoptosis rate and the expression levels of cleaved caspase-3 and lnc RNA NBR2 in Hep3B cells(P<0.05).Transfection of si-lncRNA NBR2significantly increased the proliferation rate and the protein levels of PCNA,DUSP4,and p-ERK(P<0.05)and decreased the apoptosis rate and the protein level of cleaved-caspase-3(P<0.05).Transfection of pc DNA-lnc RNA NBR2 significantly attenuated the effect of si-lnc RNA NBR2 transfection on the proliferation and apoptosis of Hep3B cells.Compared with the Ganoderma lucidum extract+si-NC group,the cell proliferation rate and the protein levels of PCNA,DUSP4,and p-ERK in the Ganoderma lucidum extract+si-Lnc RNA NBR2 group increased(P<0.05),while apoptosis and the protein level of cleaved-caspase-3 were reduced(P<0.05).Conclusion Ganoderma lucidum extract significantly reduced the activation of the DUSP4/ERK signaling pathway by upregulating the expression of LncRNA NBR2,thereby inhibiting the proliferation and increased the apoptosis of Hep3B cells.
作者 李霞 李慧 许聪聪 李军峰 张冬冬 LI Xia;LI Hui;XU Congcong;LI Junfeng;ZHANG Dongdong(Department of Oncology,Central Hospital of Zaozhuang Mining Group,Zaozhuang,Shandong 277800,China;Department of Oncology,Zaozhuang Hospital,Zaozhuang Mining Group,Zaozhuang,Shandong 277800,China;Department of Oncology,People's Hospital of Xuecheng District,Zaozhuang,Shandong 277800,China)
出处 《安徽医药》 CAS 2022年第11期2208-2212,共5页 Anhui Medical and Pharmaceutical Journal
关键词 肉灵芝提取物 长链非编码RNA BRCA1相邻基因2 DUSP4/ERK 肝癌 Ganoderma lucidum extract LncRNA NBR2 DUSP4/ERK signaling pathway Liver cancer
  • 相关文献

参考文献7

二级参考文献57

  • 1Yao Long, Xiao-Tian Lin, Kun-Lun Zeng and Lian Zhang Zhanjiang, China Department of Infectious Diseases, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China ,Haibin Centre Hospital, Zhanjiang 524005, China ,Centre of Hepatology of Nanfang Hospital, First Military Medical University, Guang- zhou 510515, China.Efficacy of intramuscular matrine in the treatment of chronic hepatitis B[J].Hepatobiliary & Pancreatic Diseases International,2004,3(1):69-72. 被引量:21
  • 2Bosch F X,Ribes J, Diaz M, et al. Primary liver cancer: world wide incidence and trends[J]. Gastroenterol, 2004, 127(5,) : S5- S16.
  • 3Bisht S, Feldmann G, Soni S, et al. Polymeric nanopartigle-en capsulated curcumin (nanocurcumin): a novel strategy for hu man cancer therapy[J]. J Nanobiotechnol, 2007, 5(3): 1-18.
  • 4Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformula tions: a future nanomedicine for cancer[J]. Drug Dis Today2012, 17(1): 71 -80.
  • 5Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology[J]. Cancer Discovery, 2011, 1(5): 391-407.
  • 6Kanwal F, Befeler A, Chari RS, et al. Potentially curative treat- ment in patients with hepatocellular cancer-results from the liver cancer research network[J]. Alim Pharmacol Ther, 2012, 36 (3) : 257-265.
  • 7Shoba G, Joy D, Joseph T, et al. Influence of plperine on the pharmacokinetics of curcumin in animals and human volunteers [J]. Planta Medica, 1998, 64(04) : 353-356.
  • 8Kunchandy E, Rao MNA. Oxygen radical scavenging activity of curcumin[J]. Intern J Pharm, 1990, 58(3): 237-240.
  • 9Wilken R, Veena MS, Wang MB, et al. Curcumin: A review of anti cancer properties and therapeutic activity in head and neck squamous cell carcinoma[J]. Mo; Cancer, 2011, 10(12): 1- 19.
  • 10Zhang B, Arun G, Mao YS, et al. The IncRNA is dispensable for mouse development but its transcription plays acis-regulatory role in the adult[J]. Cell Reports, 2012, 2(1): 111 -123.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部